Reign Resources Corporation (“Reign”) and Sigyn Therapeutics, Inc. (“Sigyn”) announced that the companies have entered into a definitive merger agreement pursuant to which Reign will acquire all of the outstanding capital stock of Sigyn in exchange for shares of Reign common stock representing approximately 75% of Reign's outstanding common stock. Upon completion of the merger transaction, Reign will be renamed Sigyn Therapeutics, Inc. and will be led by Sigyn co-founder Jim Joyce, who will serve as Chairman and CEO of the combined company. Additional announcements regarding the combined company's management structure, Board of Directors and Science Advisory Board will be forthcoming.